Loading...
Rising Global Regulations And Healthcare Pressures Will Lower Valuation
AnalystLowTarget's Fair Value
US$7.00
21.1% overvalued intrinsic discount04 Sep
US$8.48
1Y
-2.3%7D
6.7%1Y
-2.3%7D
6.7%You can edit this narrative until Aug 7 10:34 PM. Then, changes will post as Updates.